Miles Prince, MD, explains the outcomes of the ALCANZA study in CD30-expressing CTCL
4 Visningar
• 08/09/23
0
0
Bädda in
administrator
Prenumeranter
Dr. Prince, Professor, The University of Melbourne and Monash University, talks about the outcomes of the ALCANZA study in CD30-expressing CTCL
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna